Associations Between COVID‐19 Vaccination Status and Persistent Symptoms: A Prospective Study of Reproductive‐Age Women
Journal of Evaluation in Clinical Practice,
Journal Year:
2025,
Volume and Issue:
31(1)
Published: Feb. 1, 2025
The
present
study
was
conducted
to
determine
the
relationship
between
prolonged
complaints
of
women
who
had
COVID-19
infection
and
whose
symptoms
persisted
their
vaccination
status
against
COVID-19.
This
prospective
observational
consisted
three
groups
[The
Unvaccinated
Group
(Control
Group:
89),
BioNTech
Vaccine
(114
people),
Sinovac
(84
people)].
In
this
study,
which
included
287
women,
in
spouses
were
also
questioned.
Information
obtained
from
participants
form
questions
answers
under
outpatient
clinical
conditions
2
months
after
recovery.
Women
ages
18-45
regular
menstrual
periods
last
6
before
pandemic,
those
test
negative
received
a
single
dose
vaccine
vaccinated
group
study.
rates
loss
taste
high
fever
Sinovac-vaccinated
lower
than
other
(p
<
0.05).
A
total
40.5%
with
cycle
length
every
28-40
days,
higher
percentage
groups,
did
not
have
pain.
Additionally,
period
62.3%
increased
increase
is
group.
indicated
that
certain
less
common
among
Sinovac.
group,
increased,
while
pain
decreased.
Language: Английский
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
International Journal of Vaccine Theory Practice and Research,
Journal Year:
2024,
Volume and Issue:
3(2), P. 1275 - 1344
Published: Aug. 16, 2024
The
COVID-19
modified
mRNA
(modmRNA)
lipid
nanoparticle-based
“vaccines”
are
not
classical
antigen-based
vaccines
but
instead
prodrugs
informed
by
gene
therapy
technology.
Of
considerable
note,
these
products
have
been
linked
to
atypical
adverse
and
serious
event
profiles.
As
discussed
in
Part
1,
health-related
risks
drawbacks
were
drastically
misreported
underreported
the
Pfizer
Moderna
trial
evaluations
of
genetic
products.
Now
2,
we
examine
main
structural
functional
aspects
injectables.
modmRNA
injectable
introduce
a
unique
set
biological
challenges
human
body
with
potential
induce
an
extensive
range
adverse,
crippling,
life-threatening
effects.
Based
on
fact
that
there
is
no
current
method
quantify
host
(cell-based)
spike
protein
production
vivo
following
injection
prodrugs,
standard
“dose”.
This
part
due
differences
output,
which
depends
cell
metabolism
transfection
efficiency.
It
therefore
difficult
predict
profiles
individual
basis,
considering
millions
adults
across
world
reported
severe
events
context
products,
valid
concerns
raised
regarding
infants
younger
age
groups
for
whom
poses
only
minimal
risks.
We
address
process-related
impurities
inherent
mass
posed
contaminants.
then
categorize
principal
associated
brief
systems-based
synopsis
each
six
domains
harms:
(1)
cardiovascular,
(2)
neurological,
(3)
hematologic;
(4)
immunological,
(5)
oncological,
(6)
reproductive.
conclude
discussion
primary
public
health
regulatory
issues
arising
from
this
evidence-informed
synthesis
literature
reiterate
urgency
imposing
global
moratorium
modmRNA-LNP-based
platform.
Language: Английский
تأثير لقاح كوفيد -19 على الدورة الشهرية
Sarah Muafaq Al-Azawi,
No information about this author
Raida Al-Wazzan
No information about this author
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ),
Journal Year:
2024,
Volume and Issue:
7(1), P. 46 - 51
Published: July 8, 2024
Background:
The
implementation
of
vaccines
is
a
major
step
in
saving
humanity
from
the
consequences
COVID-19,
and
there
has
become
hope
for
everyone
world.
Menstruation
key
indicator
overall
women's
health.
COVID-19
vaccination
been
associated
with
changes
menstrual
cycle.
Objective:
To
evaluate
effects
on
Methods:
This
face-to-face
interview-based
cross-sectional
study
that
recruited
403
vaccinated
women
vaccine
who
had
normal
MC
before
receiving
at
least
six
months
Mosul,
Iraq,
February
1
to
July
31,
2022.
We
asked
about
their
cycle
parameters
after
vaccination.
results
were
analyzed
statistically.
Results:
most
frequent
age
group
among
participants
was
20–34
years
(52.9%).
About
half
(58.3%)
received
Pfizer
vaccine.
12.2%
13.65%
reported
significant
following
first
second
doses,
respectively.
These
included
irregularities
modifications
amount
duration
menses,
significantly
responsible
these
changes.
Conclusions:
In
small
number
vaccination,
post-Covid-19
occurred,
not
critical.
result
can
reassure
community
vaccine's
impact
Language: Английский